In order to understand how individual cells act and interact in the context of their heterogeneous tissue environment, it is imperative to examine their molecular profiles in situ. However, traditional analysis tools are limited, either disregarding the spatial component as with homogenization followed by LC-MS, or monitoring a very limited range of proteins as with immuno-based imaging. To better understand the heterogeneous tumor environment and effect better management options why not utilize more of the molecular information available in the tissue environment?
MALDI Guided SpatialOMx allows subtyping of tissue using thousands of label-free images of compounds ranging from metabolites to proteins. Further, each subpopulation of cells can be subsequently targeted for 4D-OMICS analysis to extract deepest molecular insight with spatial context that only SpatialOMx can provide.
Using the links below, learn more about a recent study that used lipid images to subtype breast tumor followed by 4D-Proteomic analysis of each subpopulation to revel that each subpopulation of cells expressed different proteomic activity.
Whether you are probing the cellular proteome, lipidome or metabolome, Imaging provides a literal map of molecular expression in the specimen. Often, knowing where molecular expression changes can be just as important as knowing if expression changes. This can be especially true if certain compounds are highly spatially concentrated or if molecules co-distribute in specific compartments, vital information that is lost when examining only homogenized samples. SpatialOMx biomarker discovery is most complete with contextualized spatial information providing important clues into intercellular communications networks that are integral to cancer growth.
Brochure: timsTOF Pro/fleX The new standard for shotgun proteomics
Four reasons to switch to 4D-Proteomics™ on the timsTOF platform. To provide concise arguments for replacement of older 3D mass spectrometers with the 4D capable, timsTOF platform and its unique TIMS (Trapped Ion Mobility Spectrometry) capability which adds the CCS dimension to retention time, precursor mass, and MS/MS.
Download Brochure
Brochure: Guide for writing successful proposals for SpatialOMx and timsTOF fleX
MALDI Guided SpatialOMx® represents a quantum advance in how tissue is analyzed. It combines a label-free imaging technique that delivers sensitive distribution mapping for both targeted and untargeted compounds, ranging from metabolites to lipids to proteins with regionally targeted 4D-Omics analysis.
Download Brochure
Need help with SpatialOMx® funding proposals?
SpatialOMx – bringing context to proteomics through molecular pathology
Dr. Shannon Cornett, MALDI Imaging Business Unit, Bruker Daltonics
View Recording
Imaging pathways: SpatialOMx captures small molecule and lipid networks across tissues to bridge metabolomics and disease
Dr. Shannon Cornett, MALDI Imaging Business Unit, Bruker Daltonics
View Recording
In situ image identification using MALDI
Dr. Janina Oetjen, Application Specialist MALDI Imaging, Bruker Daltonics
View Recording
For further information, please contact:
Sales:
ms.sales.bdal@bruker.com to arrange for a demo or to contact sales
Marketing:
Nancy Wright-Ross, Senior Marketing Manager
Nancy.wright-ross@bruker.com
For Research Use Only. Not for use in clinical diagnostic procedures.
